Parth Mehrotra - Jun 21, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
President and COO
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Jun 21, 2022
Transactions value $
-$1,633,138
Form type
4
Date filed
6/23/2022, 04:08 PM
Previous filing
Jun 8, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $120K +60K +61.61% $2.00* 157K Jun 21, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$1.24M -42.5K -27.02% $29.05 115K Jun 21, 2022 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Sale -$518K -17.5K -15.22% $29.63 97.4K Jun 21, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -60K -3.65% $0.00 1.59M Jun 21, 2022 Common Stock 60K $2.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.38 to $29.37 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.39 to $29.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.